共 57 条
[1]
Volkow ND(2014)Medication-Assisted Therapies — Tackling the Opioid-Overdose Epidemic New England Journal of Medicine. 370 2063-2066
[2]
Frieden TR(2019)Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis? Substance Abuse. 40 148-153
[3]
Hyde PS(2017)Why aren’t physicians prescribing more buprenorphine? Journal of Substance Abuse Treatment. 78 1-7
[4]
Cha SS(2014)Barriers to primary care physicians prescribing buprenorphine Annals of Family Medicine. 12 128-133
[5]
Doernberg M(2018)Methadone in primary care - one small step for congress, one giant leap for addiction treatment New England Journal of Medicine. 379 7-8
[6]
Krawczyk N(2018)Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment American Journal of Preventive Medicine. 54 S230-S242
[7]
Agus D(2019)Buprenorphine Deregulation and Mainstreaming Treatment for Opioid Use Disorder: X the X Waiver JAMA Psychiatry. 76 229-230
[8]
Fingerhood M(2019)Legal and policy changes urgently needed to increase access to opioid agonist therapy in the United States International Journal of Drug Policy. 73 42-48
[9]
Huhn AS(2020)Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic Harm reduction journal. 17 26-26
[10]
Dunn KE(2020)Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder Am J Psychiatry 177 117-124